MedTrace Logo

Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction

NCT06543628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-03-10

No results posted yet for this study

Summary

This study aims to evaluate the clinical efficacy and histological changes of tadalafil combined with low-intensity pulsed ultrasound (LIPUS) in patients with erectile dysfunction (ED) through a randomized controlled trial.

Conditions

Interventions

DRUG

Tadalafil 5mg

Participants will take tadalafil once daily at a dose of 5 mg for 6 months.

DEVICE

LIPUS (Low Intensity Pulsed Ultrasound)

Participants will receive LIPUS treatment applied twice a week for 4 weeks, with the cycle repeated after a 4-week interval without treatment.

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • Bodong Lv, MD · 2ndAffiliated Hospital, School of Medicine, Zhejiang University, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-11
Primary Completion
2025-03-01
Completion
2025-03-03

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06543628 on ClinicalTrials.gov